TAVI: Study shows 80% survival at 2 years for Direct Flow device
Direct Flow Medical says 2-year data from its Discover CE Mark trial showed an 80% survival rate at 2 years for its transcatheter aortic valve implant.
Direct Flow Medical today said data from a clinical trial of its replacement heart valve showed an 80% survival rate after 2 years.
Direct Flow Medical Inc.News Well, Clinical Trials, Replacement Heart Valvesread more
Source: Mass Device - Category: Medical Equipment Authors: Fink Densford Source Type: news
More News: Cardiology | Clinical Trials | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Medical Devices | Study